Molecular investigation into outbreak of HIV in a Scottish prison
暂无分享,去创建一个
[1] M. Leinonen,et al. Chlamydia pneumoniae antibodies and serum lipids in Finnish men: cross sectional study , 1997, BMJ.
[2] M. Uhlén,et al. Accurate reconstruction of a known HIV-1 transmission history by phylogenetic tree analysis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[3] E. Israel,et al. Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. Asthma Clinical Research Network. , 1996, The New England journal of medicine.
[4] S. J. Clark,et al. HIV-specific cellular and humoral immune responses in primary HIV infection. , 1996, AIDS research and human retroviruses.
[5] R. Zuwallack,et al. The effect of inhaled albuterol in moderate to severe asthma. , 1996, The Journal of allergy and clinical immunology.
[6] J. Parry,et al. Diverse HIV-1 genetic subtypes in UK , 1996, The Lancet.
[7] G. Bentham. Association between incidence of non-Hodgkin's lymphoma and solar ultraviolet radiation in England and Wales , 1996, BMJ.
[8] G. Giles,et al. Have increases in solar ultraviolet exposure contributed to the rise in incidence of non-Hodgkin's lymphoma? , 1996, British Journal of Cancer.
[9] P. Hartge,et al. Non-Hodgkin's lymphoma and sunlight. , 1996, Journal of the National Cancer Institute.
[10] R. Osathanondh,et al. HIV-1 Langerhans' Cell Tropism Associated with Heterosexual Transmission of HIV , 1996, Science.
[11] D. Strachan,et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors , 1995, BMJ.
[12] P. Hall,et al. Non‐Hodgkin's lymphoma and skin malignancies‐shared etiology? , 1995, International journal of cancer.
[13] B. Lipworth,et al. Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients , 1995, The Lancet.
[14] M. Melbye,et al. Evidence of an association between non-Hodgkin's lymphoma and skin cancer , 1995, BMJ.
[15] M. Dosemeci,et al. United States non-Hodgkin's lymphoma surveillance by occupation 1984-1989: a twenty-four state death certificate study. , 1995, American journal of industrial medicine.
[16] M. Ward. The immunobiology and immunopathology of chlamydial infections , 1995, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[17] S. Gore,et al. Drug injection and HIV prevalence in inmates of Glenochil prison , 1995, BMJ.
[18] J. Wrench,et al. Outbreak of HIV infection in a Scottish prison , 1995, BMJ.
[19] S. Locarnini,et al. Spread of bloodborne viruses among Australian prison entrants , 1995, BMJ.
[20] A. Perelson,et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.
[21] Martin A. Nowak,et al. Viral dynamics in human immunodeficiency virus type 1 infection , 1995, Nature.
[22] D. Hendrick,et al. Effect of eight weeks of treatment with salmeterol on bronchoalveolar lavage inflammatory indices in asthmatics. , 1994, American journal of respiratory and critical care medicine.
[23] K. Jones,et al. Salmeterol xinafoate in the treatment of mild to moderate asthma in primary care. UK Study Group. , 1994, Thorax.
[24] M. Uhlén,et al. Analysis of a rape case by direct sequencing of the human immunodeficiency virus type 1 pol and gag genes , 1994, Journal of virology.
[25] N. Mueller. Another view of the epidemiology of non-Hodgkin's lymphoma. , 1994, Oncology.
[26] A. Staines,et al. The increasing incidence of non-Hodgkin's lymphoma (NHL): the possible role of sunlight. , 1994, Leukemia & lymphoma.
[27] P. Oakley. The need for standards for inter‐hospital transfer , 1994, Anaesthesia.
[28] C. Palmer,et al. Rates of admission to hospital for asthma , 1994, BMJ.
[29] S. Rennard,et al. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma. , 1994, JAMA.
[30] J. Huelsenbeck,et al. Support for dental HIV transmission , 1994, Nature.
[31] S. Gore,et al. Study of infection with HIV and related risk factors in young offenders' institution. , 1993, BMJ.
[32] S. Gore,et al. No escape: HIV transmission in jail. , 1993, BMJ.
[33] E. Holmes,et al. Molecular investigation of human immunodeficiency virus (HIV) infection in a patient of an HIV-infected surgeon. , 1993, The Journal of infectious diseases.
[34] E. Holmes,et al. Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection , 1993, Journal of virology.
[35] W. Castle,et al. Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment. , 1993, BMJ.
[36] M. Uhlén,et al. Forensic evidence by DNA sequencing , 1993, Nature.
[37] J. Palmer,et al. Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group. , 1993, Thorax.
[38] J. Kemp,et al. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. , 1992, The New England journal of medicine.
[39] P. Barnes,et al. Tolerance to the Nonbronchodilator Effects of Inhaled β2-Agonists in Asthma , 1992 .
[40] P. Scherr,et al. Non-Hodgkin's lymphoma and occupational exposure. , 1992, Cancer research.
[41] T. Fears,et al. Non-Hodgkin's lymphoma time trends: United States and international data. , 1992, Cancer research.
[42] P. Hartge,et al. Quantification of the impact of known risk factors on time trends in non-Hodgkin's lymphoma incidence. , 1992, Cancer research.
[43] A. Blair,et al. Pesticides and non-Hodgkin's lymphoma. , 1992, Cancer research.
[44] J. Palmer,et al. A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group. , 1992, The European respiratory journal.
[45] S. Gore,et al. Anonymous HIV surveillance in Saughton Prison, Edinburgh , 1992, AIDS.
[46] J. Mullins,et al. Molecular Epidemiology of HIV Transmission in a Dental Practice , 1992, Science.
[47] T. Mackay,et al. Factors Affecting Asthma Mortality in Scotland , 1992, Scottish Medical Journal.
[48] P. Simmonds,et al. Discontinuous sequence change of human immunodeficiency virus (HIV) type 1 env sequences in plasma viral and lymphocyte-associated proviral populations in vivo: implications for models of HIV pathogenesis , 1991, Journal of virology.
[49] R. Dahl,et al. Salmeterol: a four week study of a long-acting beta-adrenoceptor agonist for the treatment of reversible airways disease. , 1991, The European respiratory journal.
[50] J. Matthews,et al. Serial correlation in the design and analysis of crossover trials , 1991 .
[51] R. Douglas,et al. HIV prevalence and risk behaviours for HIV transmission in South Australian prisons. , 1991, AIDS.
[52] P. Simmonds,et al. Detection, quantification and sequencing of HIV-1 from the plasma of seropositive individuals and from factor VIII concentrates. , 1991, AIDS.
[53] D. Vlahov,et al. Prevalence of antibody to HIV-1 among entrants to US correctional facilities. , 1991, JAMA.
[54] N. Douglas,et al. Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist. , 1990, BMJ.
[55] T Gojobori,et al. Molecular clock of viral evolution, and the neutral theory. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[56] J. Elwood,et al. Malignant melanoma in England: risks associated with naevi, freckles, social class, hair colour, and sunburn. , 1990, International journal of epidemiology.
[57] B. Pasternack,et al. Simultaneous assessment of risk factors for malignant melanoma and non-melanoma skin lesions, with emphasis on sun exposure and related variables. , 1990, International journal of epidemiology.
[58] T. Pumarola,et al. Seroepidemiology of HIV-1 infection in a Catalonian penitentiary. , 1990, AIDS.
[59] E. White,et al. Melanoma risk by age and socio‐economic status , 1990, International journal of cancer.
[60] G. Hart,et al. Risk behaviours for HIV infection among drug users in prison. , 1990, BMJ.
[61] R N Hoover,et al. The emerging epidemic of melanoma and squamous cell skin cancer. , 1989, JAMA.
[62] M. Tucker,et al. The Danish case‐control study of cutaneous malignant melanoma. II. Importance of UV‐light exposure , 1988, International journal of cancer.
[63] A. Tattersfield,et al. REBOUND INCREASE IN BRONCHIAL RESPONSIVENESS AFTER TREATMENT WITH INHALED TERBUTALINE , 1988, The Lancet.
[64] I. Ledingham,et al. Provision of facilities for secondary transport of seriously ill patients in the United Kingdom , 1988, British medical journal.
[65] J. Bion,et al. Transporting critically ill patients by ambulance: audit by sickness scoring , 1988, British medical journal.
[66] P. Burney,et al. ASTHMA MORTALITY IN ENGLAND AND WALES: EVIDENCE FOR A FURTHER INCREASE, 1974-84 , 1986, The Lancet.
[67] J. Elwood,et al. Cutaneous melanoma in relation to intermittent and constant sun exposure—the western canada melanoma study , 1985, International journal of cancer.
[68] Association of Anaesthetists of Great Britain and Ireland , 1985 .
[69] R. Burn,et al. Seasonal variation and time trends of deaths from asthma in England and Wales 1960-82. , 1984, British medical journal.
[70] J J Spinelli,et al. Pigmentation and skin reaction to sun as risk factors for cutaneous melanoma: Western Canada Melanoma Study. , 1984, British medical journal.
[71] A. Woolcock,et al. Rapid method for measurement of bronchial responsiveness. , 1983, Thorax.
[72] O. Miettinen,et al. An alternative to the proportionate mortality ratio. , 1981, American journal of epidemiology.
[73] D. Strickland,et al. Malignant melanoma: social status and outdoor work. , 1980, British Journal of Cancer.
[74] L W Green,et al. Manual for scoring socioeconomic status for research on health behavior. , 1970, Public health reports.
[75] J. Gallin,et al. Serum lipids in infection. , 1969, The New England journal of medicine.
[76] P. Walford. Deaths from asthma. , 1968, British medical journal.
[77] Samuel L. Groseclose,et al. Summary of Notifiable Diseases, United States. , 1997 .
[78] P. Simmonds,et al. Sequence analysis of virus variability based on PCR , 1995 .
[79] P. Simmonds,et al. HIV: A Practical Approach , 1995 .
[80] G. Guyatt,et al. Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol. , 1995, American journal of respiratory and critical care medicine.
[81] J. Hedner,et al. Inhaled Salmeterol and Salbutamol in Asthmatic Patients , 1990 .
[82] A. Mindel. Virology and Immunology , 1989 .
[83] C. Garland,et al. Do sunlight and vitamin D reduce the likelihood of colon cancer? , 1980, International journal of epidemiology.